KHK inhibition for the treatment of hereditary fructose intolerance and nonalcoholic fatty liver disease: a double-edged sword

Cell Mol Life Sci. 2020 Sep;77(17):3465-3466. doi: 10.1007/s00018-020-03575-y. Epub 2020 Jun 26.
No abstract available

Publication types

  • Comment

MeSH terms

  • Fructose
  • Fructose Intolerance*
  • Humans
  • Non-alcoholic Fatty Liver Disease*

Substances

  • Fructose